Actively Recruiting
Evaluating SAR448851 Oral Treatment for Early Alzheimers Disease with Placebo Control and Open-Label Extension
Led by Sanofi · Updated on 2026-10-23
160
Participants Needed
20
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the efficacy and safety of SAR448851, an oral medication taken once daily, in people with early Alzheimers disease, including mild cognitive impairment due to Alzheimers and mild Alzheimers dementia. This Phase 2 randomized, placebo-controlled study focuses on participants aged 55 to 85 years who have evidence of cerebral amyloid pathology. The study aims to measure changes in plasma biomarkers and monitor safety outcomes over time. Participants are randomly assigned to receive either SAR448851 at one of two doses or a placebo, taken orally once daily for 48 weeks during Part A. Those who complete Part A can join an open-label extension in Part B. The total study duration may last up to 111 weeks for Parts A and B, or up to 63 weeks for the optional dose 2 cohort. Various assessments, including brain imaging and fluid biomarker measurements, will be used to evaluate treatment effects. Throughout the trial, participants will have regular evaluations including brain MRIs to monitor for adverse events such as ARIA-E and ARIA-H, laboratory tests, vital sign checks, ECGs, and cognitive assessments. Researchers will track changes in Alzheimers disease biomarkers from baseline through Week 96. Safety and tolerability will be continuously assessed, and participants cognitive status will be monitored to understand the treatments impact over time.
CONDITIONS
Brief Title
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Research Team
T
Trial Transparency email recommended (Toll free for US & Canada)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here